Human Xtensions Valuation
| HUMX Stock | ILA 30.30 0.10 0.33% |
At this time, the firm appears to be overvalued. Human Xtensions retains a regular Real Value of 27.15 per share. The prevalent price of the firm is 30.3. Our model calculates the value of Human Xtensions from evaluating the firm fundamentals such as Shares Outstanding of 26.76 M, return on equity of -0.5, and Return On Asset of -0.27 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Human Xtensions' price fluctuation is somewhat reliable at this time. Calculation of the real value of Human Xtensions is based on 3 months time horizon. Increasing Human Xtensions' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Human Xtensions is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Human Stock. However, Human Xtensions' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 30.3 | Real 27.15 | Hype 30.3 | Naive 29.62 |
The real value of Human Stock, also known as its intrinsic value, is the underlying worth of Human Xtensions Company, which is reflected in its stock price. It is based on Human Xtensions' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Human Xtensions' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Human Xtensions helps investors to forecast how Human stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Human Xtensions more accurately as focusing exclusively on Human Xtensions' fundamentals will not take into account other important factors: Human Xtensions Total Value Analysis
Human Xtensions is currently forecasted to have takeover price of (47.61 M) with market capitalization of 28.63 M, debt of 7.55 M, and cash on hands of 148.31 M. The negative valuation of Human Xtensions may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should thoroughly investigate all of the Human Xtensions fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(47.61 M) | 28.63 M | 7.55 M | 148.31 M |
Human Xtensions Investor Information
About 55.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.27. Some equities with similar Price to Book (P/B) outperform the market in the long run. Human Xtensions recorded a loss per share of 2.01. The entity had not issued any dividends in recent years. Based on the key indicators related to Human Xtensions' liquidity, profitability, solvency, and operating efficiency, Human Xtensions is not in a good financial situation at the moment. It has a very high risk of going through financial straits in April.Human Xtensions Asset Utilization
One of the ways to look at asset utilization of Human is to check how much profit was generated for every dollar of assets it reports. Human Xtensions retains a negative application of resources of -0.27 (percent), losing 0.002713 for each of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each of resources it retains. Simply put, asset utilization of Human Xtensions shows how discouraging it operates for each spent on its resources.Human Xtensions Ownership Allocation
Human Xtensions has a total of 26.76 Million outstanding shares. Human Xtensions secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Human Xtensions Profitability Analysis
The company reported the revenue of 3.12 M. Net Loss for the year was (28.54 M) with profit before overhead, payroll, taxes, and interest of 1.62 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Human Xtensions' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Human Xtensions and how it compares across the competition.
About Human Xtensions Valuation
The stock valuation mechanism determines Human Xtensions' current worth on a weekly basis. Our valuation model uses a comparative analysis of Human Xtensions. We calculate exposure to Human Xtensions's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Human Xtensions's related companies.It offers HandX, a handheld medical device for use in laparoscopic procedures. The company was founded in 2012 and is based in Netanya, Israel. HUMAN XTENSIONS operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 58 people.
8 Steps to conduct Human Xtensions' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Human Xtensions' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Human Xtensions' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Human Xtensions' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Human Xtensions' revenue streams: Identify Human Xtensions' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Human Xtensions' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Human Xtensions' growth potential: Evaluate Human Xtensions' management, business model, and growth potential.
- Determine Human Xtensions' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Human Xtensions' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Human Stock analysis
When running Human Xtensions' price analysis, check to measure Human Xtensions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Human Xtensions is operating at the current time. Most of Human Xtensions' value examination focuses on studying past and present price action to predict the probability of Human Xtensions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Human Xtensions' price. Additionally, you may evaluate how the addition of Human Xtensions to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |